Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study

201638 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Osteoporosis International

Volume 27, Issue 6, pp. 2099-2107

Field-Weighted Citation Impact: 3.13